Pharmafile Logo
Pharmafocus logo
Advanced Search
epi-pen_1_3

Study reveals EpiPens stay effective years after expiration date

May 10, 2017
Research and Development EpiPen expiration, Mylan, Mylan scandal, epipen

The Annals of Internal Medicine has published a study that indicated that EpiPen injectors retain a medically significant proportion of …

News
scott_gottlieb

Scott Gottlieb appointed to the FDA’s top role

May 10, 2017
Manufacturing and Production, Research and Development, Sales and Marketing FDA, Scott Gottlieb, Trump

After months of scrutiny, Scott Gottlieb has been confirmed as the new Commissioner of the FDA, following his nomination by …

News
dr_sonia_quaratino

Kymab instates first Chief Medical Officer

May 9, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, kymab

Kymab, a therapeutic antibody company based in Cambridge, UK, has announced that it has appointed Dr Sonia Quaratino as its …

Appointment
money_packets

Duchenne drug poised to cost $35,000 but with major catch

May 9, 2017
Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, PTC Therapeutics, marathon

For those that have not followed the story, Emflaza was successfully taken through the FDA regulatory process by Marathon as …

News
dna-1903319_960_720

University of Oxford gains access to biomarker profiling technology

May 9, 2017
Manufacturing and Production, Research and Development Nightingale health, University of Oxford

The University of Oxford has announced that it will benefit from Nightingale Health’s biomarker analysis technology. The Finnish company will …

News

73% of India’s doctors oppose prescribing generics over branded versions

May 9, 2017
Manufacturing and Production, Sales and Marketing India, generics

Following a recent push by Indian Prime Minister Narendra Modi for doctors in the country to prescribe generic drugs over …

News
eef

The Manufacturer’s Organisation calls for robust industrial strategy with new manifesto

May 9, 2017
Manufacturing and Production EFF, The Manufacter's Organisaion

With the 8 June general election only a month away, the EEF – The Manufacturer’s Organisation – has become the …

News
pills-384846_960_720

£6 million statin study to determine potential therapeutic use in MS

May 9, 2017
Manufacturing and Production, Research and Development multiple sclerosis, statins

A large study will take place in the UK to determine whether statins, commonly prescribed to combat “bad cholesterol”, are …

News

Pricing Consultant Job Profile and Description

May 8, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

About Global Pricing Innovations (GPI)

Appointment

Head of Product Innovation Job Profile and Description

May 8, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

About Global Pricing Innovations (GPI)

Appointment
happy_doctor

Patient reported outcomes: Putting the patient first

May 8, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

With clinical practice marching towards a more precision-oriented methodology, assessment of treatment efficacy is undergoing a transformation. Matt Fellows explores the …

Feature
teva_copy

Teva and Active Biotech hit by Phase 3 drug failure

May 8, 2017
Research and Development, Sales and Marketing Active Biotech, Teva

Teva and Active Biotech have been collaborating on the drug laquinimod since 2004 but it now looks like the work put …

News
scale-403585_960_720

Weight loss pill treatment rejected by NICE

May 8, 2017
Medical Communications, Sales and Marketing NICE, orexigen

NICE has announced, in an Appraisal Consultation Document, that it is not able to recommend Orexigen’s Mysimba as a weight …

News
office-space-1988480_960_720

Board battle scuppers Seattle Genetics’ $2 billion licensing deal

May 8, 2017
Sales and Marketing Immunomedics, Seattle Genetics, venBio

In another example of the influence that activist investors can have on the direction of a business, the potentially $2 …

News

NHS staff feeling the pay squeeze, reports NHS Providers

May 8, 2017
Medical Communications, Sales and Marketing NHS, NHS Providers

NHS Providers, the membership organisation and trade association for the NHS, has laid a stark warning at the door of …

News

FDA approves first new treatment for ALS in two decades

May 8, 2017
Sales and Marketing MLS, Mitsubishi Tanabe Pharma America, Radicava

The FDA has approved only the second form of treatment for amyotrophic lateral sclerosis (ALS), with the previous drug, riluzole, …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday again, and today marks the press date of the latest edition of Pharmafile, our bi-annual life sciences market …

News

Pfizer offers breast cancer drug for free following NICE rejection

May 5, 2017
Medical Communications, Sales and Marketing NICE, Pfizer

Following NICE’s decision rejecting Pfizer’s breast cancer therapy Ibrance (palbociclib) for use on the NHS, the manufacturer has announced that …

News
exit-1722888_960_720

Regulus CEO heads to exit as company struggles with FDA hold

May 5, 2017
Medical Communications, Research and Development Regulus, hepatitis C

Regulus seemed to be in a good place just last year as its lead drug candidate performed well in a …

News
talc_mine

J&J chalks up another defeat in $110 million talc-cancer case

May 5, 2017
Medical Communications Johnson & Johnson, baby powder

Johnson & Johnson has suffered another defeat in a lawsuit against its talcum powder product. The latest case stands as …

News
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026